Caligan Partners LP
Top Portfolio Positions
25 positions ·
$1,620,686,473 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| LQDA |
Liquidia Corp
Healthcare
|
8,118,892 | $306,406,984 | 18.91% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
1,881,708 | $182,996,103 | 11.29% | |
| ABVX |
Abivax S.A.
Healthcare
|
1,461,924 | $162,785,237 | 10.04% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
2,060,719 | $119,748,381 | 7.39% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
1,393,027 | $81,004,520 | 5.00% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
2,772,654 | $75,111,196 | 4.63% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
2,876,140 | $70,925,612 | 4.38% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
1,553,262 | $66,619,407 | 4.11% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
15,934,414 | $61,028,804 | 3.77% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
900,000 | $60,912,000 | 3.76% |
Portfolio Trend
14 quarters · across all stocks
Holdings in EXEL
Shares Held
Position Value (USD)
13 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,619,407 | 1,553,262 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,079,473 | 1,553,262 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $63,012,649 | 1,525,730 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,254,178 | 1,525,730 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,329,951 | 1,525,730 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,806,809 | 1,525,730 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,592,693 | 1,525,730 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,283,153 | 1,525,730 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,120,322 | 1,100,730 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,848,412 | 910,730 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,899,450 | 910,730 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,404,050 | 910,730 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,498,500 | 850,000 | Shares | Sole | 2023-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||